menu
Interestingly, the majority (>55%) of such service providers firms are based in Europe, claims Roots Analysis
Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy.

Repurposingof marketed / shelved / pipeline candidates for the treatment of diseases(different from original target indications) has emerged as a viable businessstrategy. The rising popularity of this approach can further be attributed tovarious benefits, such as reduced development timelines, decreased investmentsand relatively higher success rates (considering that the safety profiles ofsuch candidates have already been established).

 

To order this 250+ page report, which features 100+ figuresand 140+ tables, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

TheUSD 1.2 billion (by 2030) financial opportunity within the drug repurposingservice providers market has been analyzed across the following segments:

§  Typeof Repurposing Approaches

§  Disease-centricapproach

§  Target-centricapproach

§  Drug-centricapproach

§  TherapeuticArea

§  SameTherapeutic Area

§  DifferentTherapeutic Area

§  Typeof Drug Molecule

§  Biologics 

§  SmallMolecule

§  KeyGeographical Region 

§  NorthAmerica

§  Europe

§  Asia-Pacific

 

The DrugRepurposing Service Providers Market, 2020-2030 report features the following companies, which weidentified to be key players in this domain:

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

 

To Request for sample report -  https://www.rootsanalysis.com/reports/drug-repurposing-service-provides/request-sample.html

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Market Landscape

5. Role of Non-Profit / Academic Organizations

 

6. Company Profiles

7.  Partnerships

8. Big Pharma Initiatives

9. Case Study: Discontinued Drug Development Programs

10. Cost Saving Analysis

11. Market Forecast and Opportunity Analysis

12.  Covid-19 Impact onDrug Repurposing Service Providers Market

13. Recent Advancements and Trends in Outsourcing of DrugRepurposing

 

14. Interview Transcripts

 

15. Appendix 1: List of Potential Drug-Indication Candidates forDrug Repurposing

 

16. Appendix 2: Tabulated Data

 

17. Appendix 3: List of Companies and Organizations

 

Topurchase a copy, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

Other Recent Offerings

1.     ViralVectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4thEdition), 2021-2030

2.     GlobalT-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2020-2030

3.     OncolyticVirus Therapy Market: Pipeline Review, Developer Landscape and CompetitiveInsights, 2020-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

 

Contact Information

RootsAnalysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis